A study has found that people with terminal lung or skin cancers lived twice as long if they received immunotherapy drugs - at the start of the day instead of after lunchtime. Read this story
A study has found that people with terminal lung or skin cancers lived twice as long if they received immunotherapy drugs - at the start of the day instead of after lunchtime. Read this story
More from dailym.ai | dailymail health Cancer France Paris